flavamed 30 mg tabletti
berlin-chemie ag - ambroxol hydrochloride - tabletti - 30 mg - ambroksoli
flavamed 6 mg/ml oraaliliuos
berlin-chemie ag - ambroxol hydrochloride - oraaliliuos - 6 mg/ml - ambroksoli
ambroxol ratiopharm 3 mg/ml oraaliliuos
teva b.v. - ambroxol hydrochloride - oraaliliuos - 3 mg/ml - ambroksoli
ambroxol ratiopharm 6 mg/ml oraaliliuos
teva b.v. - ambroxol hydrochloride - oraaliliuos - 6 mg/ml - ambroksoli
dengvaxia
sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - - rokotteet - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 ja 4. käyttö dengvaxia pitäisi olla virallisten suositusten mukaisesti.